Challenges in Implementing Genomic Medicine: The Mayo Clinic Center for Individualized Medicine

被引：34

作者：

Farrugia, G. ^{[1
,3
]}

Weinshilboum, R. M. ^{[2
,3
]}

机构：

[1] Mayo Clin, Div Gastroenterol, Dept Med, Rochester, MN USA

[2] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN USA

[3] Mayo Clin, Ctr Individualized Med, Rochester, MN USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 94卷 / 02期

基金：

美国国家卫生研究院;

关键词：

PHARMACOGENOMICS;

D O I：

10.1038/clpt.2013.52

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

The Mayo Clinic Center for Individualized Medicine (CIM) is designed to discover and integrate the latest in genomic, molecular, and clinical science into personalized care for patients across a multiple-site academic medical center. Despite a highly integrated structure, fully electronic medical record, and strong administrative support, achievement of this goal has had challenges. This article will describe the activities of the CIM, with emphasis on the strategy being used to clinically implement genomics.

引用

页码：204 / 206

页数：3

共 4 条

[1]

Kitzmiller JP, 2012, PHARMACOGENOMICS, V13, P751, DOI [10.2217/PGS.12.46, 10.2217/pgs.12.46]

[2]

The Impact of Pharmacogenomics on the Management of Cardiac Disease [J].

Pereira, N. L. ;

Weinshilboum, R. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (04) :493-495

[3]

Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project [J].

Pulley, J. M. ;

Denny, J. C. ;

Peterson, J. F. ;

Bernard, G. R. ;

Vnencak-Jones, C. L. ;

Ramirez, A. H. ;

Delaney, J. T. ;

Bowton, E. ;

Brothers, K. ;

Johnson, K. ;

Crawford, D. C. ;

Schildcrout, J. ;

Masys, D. R. ;

Dilks, H. H. ;

Wilke, R. A. ;

Clayton, E. W. ;

Shultz, E. ;

Laposata, M. ;

McPherson, J. ;

Jirjis, J. N. ;

Roden, D. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) :87-95

[4]

Weinshilboum Richard M, 2002, Trans Am Clin Climatol Assoc, V113, P91

← 1 →